Glossary · 2026-09-24
By Alice Kay · Last reviewed 24 Sep 2026
Solid-phase peptide synthesis, lab note
Research-use notice: This article summarizes published scientific literature for educational purposes. It is not medical advice and does not provide dosing, administration or human-use information. Findings described in the literature do not apply to any BlueNex Labs product, which is supplied only for in-vitro laboratory research and not for human or animal use.
Solid-phase peptide synthesis builds a chain on an insoluble resin by repeated coupling and deprotection, then cleaves the chain from the resin. Cleavage and purification are one reason trifluoroacetate can remain as a counter-ion. That is a manufacturing context for the salt language on a COA. It is not a method this website teaches.
BlueNex Labs sells the lyophilized research solid and, when a lot is published, the analytical file for that lot. It does not publish a synthesis procedure, a resin choice, or a cleavage recipe. Read the finished-vial records in the COA guide and the salt terms. Research use only.
Published lot files for this catalogue are indexed in the certificates library. This definition does not add a report, and it does not assign a task identifier. Research use only.
Frequently asked questions
- Does a catalogue page document how the peptide was assembled?
- No. The page identifies a research solid and points at a lot file when one is published. Assembly steps are not part of the listing.
- Why mention synthesis beside a TFA salt?
- Because TFA often remains from cleavage of a synthetic peptide. The lot file still has to name the species. The glossary does not assume it.
Research use only. BlueNex Labs does not provide medical or veterinary advice. Confirm your institution’s policies before purchase. How a comparison or class note is checked sits on documentation standards. Articles are written and reviewed by Alice Kay, Ph.D.